Drug Information

General Information
Drug ID
DR00259
Drug Name
Cefaclor
Synonyms
(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472
Drug Type
Small molecular drug
Indication Gram-positive & negative bacteria infections [ICD11: 1A00-1H0Z] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C15H14ClN3O4S
Canonical SMILES
C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
InChI
InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1
InChIKey
QYIYFLOTGYLRGG-GPCCPHFNSA-N
CAS Number
CAS 53994-73-3
Pharmaceutical Properties Molecular Weight 367.8 Topological Polar Surface Area 138
Heavy Atom Count 24 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
-1.8
PubChem CID
51039
PubChem SID
11342218 , 11362401 , 11363964 , 11366526 , 11369088 , 11372875 , 11373525 , 11377250 , 11466513 , 11467130 , 11467633 , 11468250 , 11484973 , 11486006 , 11486818 , 11487803 , 11489005 , 11491673 , 11491908 , 11494884 , 12013565 , 14803830 , 14852885 , 24278331 , 26612067 , 26680440 , 29215008 , 34715524 , 46386958 , 46507693 , 47425324 , 47425325 , 47574401 , 47647541 , 47796074 , 48020027 , 48095565 , 48170475 , 48244405 , 48244406 , 48415708 , 48484011 , 49681804 , 49698517 , 625389 , 7847322 , 7978871 , 8181891 , 855765 , 9094
ChEBI ID
CHEBI:3478
TTD Drug ID
D0PW7C
DT(s) Transporting This Drug OAT1 Transporter Info Organic anion transporter 1 Substrate [2]
OAT3 Transporter Info Organic anion transporter 3 Substrate [3]
PEPT1 Transporter Info Peptide transporter 1 Substrate [4]
PEPT2 Transporter Info Peptide transporter 2 Substrate [5]
Drug-Transporter Activity Data
Drug-Transporter Activity Data PEPT2 Transporter Info Km = 72 microM Madin-Darby canine kidney (MDCK) cells-PEPT2 [5]
References
1 Cefaclor was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 FDA Drug Development and Drug Interactions
3 Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005 Oct 1;70(7):1104-13.
4 Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G895-902.
5 Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters. Drug Metab Dispos. 2006 Apr;34(4):547-55.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.